“The Medicines Agency should speed up phase III of the plitidepsin trial”

R. Ibarra

Madrid

Updated:

save

“The results of the study are very good,” says Vicente Estrada, head of the Infectious Diseases Service of the Hospital Clínico-San Carlos de Madrid and one of the two coordinators of the phase I / II trial carried out with plitidepsin (aplidine) on 45 patients from 13 Spanish hospitals.

Therefore, he is confident that the phase III trial will start shortly. In a situation where we have nothing except remdesivir and dexamethasone, which have a limited effect, ‘it is necessary to test the potency of this drug in patients», He says. In his opinion, the Medicines Agency should “” expedite the phase III clinical trial. “

This study will try to demonstrate the superiority of plitidepsin in combination with remdesivir and dexamateson in front of

Leave a Reply

Your email address will not be published. Required fields are marked *